Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies
- 1 July 2016
- journal article
- research article
- Published by Elsevier BV in The Journal of Molecular Diagnostics
- Vol. 18 (4), 507-515
- https://doi.org/10.1016/j.jmoldx.2016.02.003
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Acute myeloid leukemia ontogeny is defined by distinct somatic mutationsBlood, 2015
- Assessing Copy Number Alterations in Targeted, Amplicon-Based Next-Generation Sequencing DataThe Journal of Molecular Diagnostics, 2014
- Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasmsBlood, 2014
- Mutations in the cohesin complex in acute myeloid leukemia: clinical and prognostic implicationsBlood, 2014
- Somatic Mutations of Calreticulin in Myeloproliferative NeoplasmsNew England Journal of Medicine, 2013
- The biology and clinical impact of genetic lesions in myeloid malignanciesBlood, 2013
- Targeted Inhibition of Mutant IDH2 in Leukemia Cells Induces Cellular DifferentiationScience, 2013
- Gene mutations and molecularly targeted therapies in acute myeloid leukemia2013
- The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone developmentThe Journal of Experimental Medicine, 2012
- Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic LeukemiaScience, 2004